Brazil's Pharmaceuticals in Dosage Market saw fluctuating growth over the past decade. The market value peaked in 2014 at 31.857 billion US dollars and then experienced significant volatility, dropping sharply in 2015 by approximately 19.02%. The following years showed mixed growth rates with the market oscillating between gains and losses. The year 2018 marked a notable decline of 9.73%. In recent years, the market saw minor fluctuations with a 5.67% decrease in 2022. The 5-year compound annual growth rate (CAGR) from 2018-2022 was -1.76%, indicating an overall downward trend.
Looking into the future, industry observers should monitor advancements in biotechnology, regulatory changes, and healthcare reforms that could impact market dynamics. Additionally, trends such as the increasing adoption of personalized medicine and the development of new drug delivery systems could present both opportunities and challenges for market growth.
How does Brazil rank in Pharmaceuticals in Dosage Market Size Value?
| # | 59 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 110,040,000,000 | 2023 | -0.57% | +2.9% | View data |
| 2 | 2 Japan | 102,270,000,000 | 2023 | +1.29% | +1.27% | View data |
| 3 | 3 Italy | 90,420,000,000 | 2023 | -0.45% | +3.03% | View data |
| 4 | 4 France | 70,241,000,000 | 2023 | -2.11% | -1.64% | View data |
| 5 | 5 United Kingdom | 69,574,000,000 | 2023 | -0.43% | -2.13% | View data |
| 6 | 6 Spain | 40,114,000,000 | 2023 | -4.01% | -0.84% | View data |
| 7 | 7 Canada | 32,850,000,000 | 2023 | -2.34% | +0.84% | View data |
| 8 | 8 Brazil | 24,977,000,000 | 2023 | -0.94% | +0.08% | |
| 9 | 9 Australia | 20,581,000,000 | 2023 | -7.45% | -6.31% | View data |
| 10 | 10 Poland | 12,625,000,000 | 2023 | -2.37% | -1.14% | View data |